Institutions bought this cannabis stock ahead of rescheduling progress, but did they sell on the news?

Tilray Brands' international revenue surge, beverage scale and strong cash position give it an edge over Canopy Growth as cannabis regulation and demand continue to evolve.

The Global Cannabis Stock Index closed on 2/11 at 5.69, which is down 3.4% in February and down 13.7% so far in 2026. Since April 30, 2024, it has plunged 51.4%. Five years ago, the index peaked at 92 ...

Cannabis stocks rallied Wednesday morning following fresh reports that President Donald Trump is poised to sign an executive order rescheduling marijuana from Schedule I to Schedule III. The news sent ...

Donald Trump signed an executive order on Dec. 18 to fast-track the Food and Drug Administration's review to reclassify cannabis as a Schedule III substance under the Controlled Substances Act. Pot ...